Skip to main content
OpenTrials

Clinical trial condition

Leptomeningeal Metastasis

Explore clinical trials studying Leptomeningeal Metastasis. Study availability and eligibility vary by location and protocol.

47 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Leptomeningeal Metastasis trial results

Active, not recruiting

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

NCT04192981

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +9 more
Locations
  • BAPTIST ALLIANCE - MCI (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (All protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only) Montvale, New Jersey, United States
View Trial Details
Active, not recruiting

Intrathecal Double Checkpoint Inhibition

NCT05598853

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
Locations
  • University Hospital Zurich Zurich, Canton of Zurich, Switzerland
  • University Hospital Basel Basel, Switzerland
  • University Hospital Geneva Geneva, Switzerland
View Trial Details
Active, not recruiting

Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

NCT05034497

Conditions
Central Nervous System Neoplasms, Leptomeningeal Metastasis, Meningeal Carcinomatosis, +5 more
Locations
  • Northwestern Memorial Hospital Olson Pavilion Chicago, Illinois, United States
  • Northshore University Hospital Manhasset, New York, United States
  • Lenox Hill Hospital New York, United States
  • Ohio State University Hospital Columbus, Ohio, United States
View Trial Details
Completed

DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease

NCT04420598

Conditions
Advanced Breast Cancer, Brain Diseases, Brain Metastases, +19 more
Locations
  • Champalimaud Center for the Unknown Lisbon, Portugal
  • Instituto Português de Oncologia do Porto Francisco Gentil, EPE (IPO Porto) Porto, Portugal
  • Institut Català d'Oncologica ICO Badalona Badalona, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
View all 16 locations
View Trial Details
Completed

Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

NCT04233021

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +11 more
Locations
  • Centre Hospitalier Aix-Pertuis Aix-en-Provence, France
  • CHU Amiens - Groupe Hospitalier Sud Amiens, France
  • Centre Paul Papin Angers, France
  • Hôpital privé d'Antony Antony, France
View all 36 locations
View Trial Details

Related conditions